1 results match your criteria: "Kellogg Eye Center and University of Michigan Medical School[Affiliation]"
Re: Shah et al.: Teprotumumab-related adverse events in thyroid eye disease: a multicenter study (Ophthalmology. 2024;131:458-467).
Ophthalmology
June 2024
Kellogg Eye Center and University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: